Segment disclosures

Company overview

CAREFUSION CORP

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

23 dimension combinations 233 retained observations 19 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Sales Revenue Segment · Dispensing Technologies · Medical Systems

Concentration Risk By Benchmark · Product Or Service · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:ProductOrServiceAxis=cfn:DispensingTechnologiesMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-30211000000 USD20131210Open filing evidence
2012-07-01 – 2013-06-30993000000 USD20131210Open filing evidence
2012-07-01 – 2012-09-30244000000 USD20131210Open filing evidence
2011-07-01 – 2012-06-301038000000 USD20131210Open filing evidence
2010-07-01 – 2011-06-30910000000 USD20131210Open filing evidence

Sales Revenue Segment · Infection Prevention · Procedural Solutions

Concentration Risk By Benchmark · Product Or Service · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:ProductOrServiceAxis=cfn:InfectionPreventionMember;us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-30149000000 USD20131210Open filing evidence
2012-07-01 – 2013-06-30594000000 USD20131210Open filing evidence
2012-07-01 – 2012-09-30144000000 USD20131210Open filing evidence
2011-07-01 – 2012-06-30576000000 USD20131210Open filing evidence
2010-07-01 – 2011-06-30568000000 USD20131210Open filing evidence

Sales Revenue Segment · Infusion Systems · Medical Systems

Concentration Risk By Benchmark · Product Or Service · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:ProductOrServiceAxis=cfn:InfusionSystemsMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-30219000000 USD20131210Open filing evidence
2012-07-01 – 2013-06-30916000000 USD20131210Open filing evidence
2012-07-01 – 2012-09-30203000000 USD20131210Open filing evidence
2011-07-01 – 2012-06-30955000000 USD20131210Open filing evidence
2010-07-01 – 2011-06-30889000000 USD20131210Open filing evidence

Sales Revenue Segment · Medical Specialties · Procedural Solutions

Concentration Risk By Benchmark · Product Or Service · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:ProductOrServiceAxis=cfn:MedicalSpecialtiesMember;us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-3089000000 USD20131210Open filing evidence
2012-07-01 – 2013-06-30344000000 USD20131210Open filing evidence
2012-07-01 – 2012-09-3080000000 USD20131210Open filing evidence
2011-07-01 – 2012-06-30317000000 USD20131210Open filing evidence
2010-07-01 – 2011-06-30322000000 USD20131210Open filing evidence

Sales Revenue Segment · Other Medical Systems · Medical Systems

Concentration Risk By Benchmark · Product Or Service · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:ProductOrServiceAxis=cfn:OtherMedicalSystemsMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-306000000 USD20131210Open filing evidence
2012-07-01 – 2013-06-3027000000 USD20131210Open filing evidence
2012-07-01 – 2012-09-307000000 USD20131210Open filing evidence
2011-07-01 – 2012-06-3026000000 USD20131210Open filing evidence
2010-07-01 – 2011-06-3024000000 USD20131210Open filing evidence

Sales Revenue Segment · Other Procedural Solutions · Procedural Solutions

Concentration Risk By Benchmark · Product Or Service · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:ProductOrServiceAxis=cfn:OtherProceduralSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember
PeriodValueUnitFiledEvidence
2010-07-01 – 2011-06-3032000000 USD20131210Open filing evidence

Sales Revenue Segment · Respiratory Technologies · Medical Systems

Concentration Risk By Benchmark · Product Or Service · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:ProductOrServiceAxis=cfn:RespiratoryTechnologiesMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-3088000000 USD20131210Open filing evidence
2012-07-01 – 2013-06-30393000000 USD20131210Open filing evidence
2012-07-01 – 2012-09-3097000000 USD20131210Open filing evidence
2011-07-01 – 2012-06-30420000000 USD20131210Open filing evidence
2010-07-01 – 2011-06-30391000000 USD20131210Open filing evidence

Sales Revenue Segment · Specialty Disposables · Procedural Solutions

Concentration Risk By Benchmark · Product Or Service · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:ProductOrServiceAxis=cfn:SpecialtyDisposablesMember;us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-3068000000 USD20131210Open filing evidence
2012-07-01 – 2013-06-30283000000 USD20131210Open filing evidence
2012-07-01 – 2012-09-3062000000 USD20131210Open filing evidence
2011-07-01 – 2012-06-30266000000 USD20131210Open filing evidence
2010-07-01 – 2011-06-30304000000 USD20131210Open filing evidence

Sales Revenue Segment · Medical Systems

Concentration Risk By Benchmark · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-30524000000 USD20131210Open filing evidence
2012-07-01 – 2013-06-302329000000 USD20131210Open filing evidence
2012-07-01 – 2012-09-30551000000 USD20131210Open filing evidence
2011-07-01 – 2012-06-302439000000 USD20131210Open filing evidence
2010-07-01 – 2011-06-302214000000 USD20131210Open filing evidence

Sales Revenue Segment · Procedural Solutions

Concentration Risk By Benchmark · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-30306000000 USD20131210Open filing evidence
2012-07-01 – 2013-06-301221000000 USD20131210Open filing evidence
2012-07-01 – 2012-09-30286000000 USD20131210Open filing evidence
2011-07-01 – 2012-06-301159000000 USD20131210Open filing evidence
2010-07-01 – 2011-06-301226000000 USD20131210Open filing evidence

Dispensing Technologies · Medical Systems

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cfn:DispensingTechnologiesMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember
PeriodValueUnitFiledEvidence
2014-10-01 – 2014-12-31264000000 USD20150206Open filing evidence
2014-07-01 – 2014-12-31489000000 USD20150206Open filing evidence
2014-07-01 – 2014-09-30225000000 USD20141107Open filing evidence
2013-07-01 – 2014-06-30954000000 USD20140811Open filing evidence
2014-01-01 – 2014-03-31233000000 USD20140506Open filing evidence
2013-07-01 – 2014-03-31680000000 USD20140506Open filing evidence
2013-10-01 – 2013-12-31236000000 USD20150206Open filing evidence
2013-07-01 – 2013-12-31447000000 USD20150206Open filing evidence
2013-07-01 – 2013-09-30211000000 USD20141107Open filing evidence
2012-07-01 – 2013-06-30993000000 USD20140811Open filing evidence
2013-01-01 – 2013-03-31234000000 USD20140506Open filing evidence
2012-07-01 – 2013-03-31738000000 USD20140506Open filing evidence
2012-10-01 – 2012-12-31260000000 USD20140206Open filing evidence
2012-07-01 – 2012-09-30244000000 USD20131108Open filing evidence
2011-07-01 – 2012-06-301038000000 USD20140811Open filing evidence

Infection Prevention · Procedural Solutions

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cfn:InfectionPreventionMember;us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember
PeriodValueUnitFiledEvidence
2014-10-01 – 2014-12-31180000000 USD20150206Open filing evidence
2014-07-01 – 2014-12-31347000000 USD20150206Open filing evidence
2014-07-01 – 2014-09-30167000000 USD20141107Open filing evidence
2013-07-01 – 2014-06-30656000000 USD20140811Open filing evidence
2014-01-01 – 2014-03-31168000000 USD20140506Open filing evidence
2013-07-01 – 2014-03-31485000000 USD20140506Open filing evidence
2013-10-01 – 2013-12-31168000000 USD20150206Open filing evidence
2013-07-01 – 2013-12-31317000000 USD20150206Open filing evidence
2013-07-01 – 2013-09-30149000000 USD20141107Open filing evidence
2012-07-01 – 2013-06-30594000000 USD20140811Open filing evidence
2013-01-01 – 2013-03-31150000000 USD20140506Open filing evidence
2012-07-01 – 2013-03-31446000000 USD20140506Open filing evidence
2012-10-01 – 2012-12-31152000000 USD20140206Open filing evidence
2012-07-01 – 2012-09-30144000000 USD20131108Open filing evidence
2011-07-01 – 2012-06-30576000000 USD20140811Open filing evidence

Infusion Systems · Medical Systems

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cfn:InfusionSystemsMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember
PeriodValueUnitFiledEvidence
2014-10-01 – 2014-12-31269000000 USD20150206Open filing evidence
2014-07-01 – 2014-12-31482000000 USD20150206Open filing evidence
2014-07-01 – 2014-09-30213000000 USD20141107Open filing evidence
2013-07-01 – 2014-06-301037000000 USD20140811Open filing evidence
2014-01-01 – 2014-03-31238000000 USD20140506Open filing evidence
2013-07-01 – 2014-03-31704000000 USD20140506Open filing evidence
2013-10-01 – 2013-12-31247000000 USD20150206Open filing evidence
2013-07-01 – 2013-12-31466000000 USD20150206Open filing evidence
2013-07-01 – 2013-09-30219000000 USD20141107Open filing evidence
2012-07-01 – 2013-06-30916000000 USD20140811Open filing evidence
2013-01-01 – 2013-03-31246000000 USD20140506Open filing evidence
2012-07-01 – 2013-03-31678000000 USD20140506Open filing evidence
2012-10-01 – 2012-12-31229000000 USD20140206Open filing evidence
2012-07-01 – 2012-09-30203000000 USD20131108Open filing evidence
2011-07-01 – 2012-06-30955000000 USD20140811Open filing evidence

Medical Specialties · Procedural Solutions

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cfn:MedicalSpecialtiesMember;us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember
PeriodValueUnitFiledEvidence
2014-10-01 – 2014-12-3196000000 USD20150206Open filing evidence
2014-07-01 – 2014-12-31187000000 USD20150206Open filing evidence
2014-07-01 – 2014-09-3091000000 USD20141107Open filing evidence
2013-07-01 – 2014-06-30364000000 USD20140811Open filing evidence
2014-01-01 – 2014-03-3191000000 USD20140506Open filing evidence
2013-07-01 – 2014-03-31269000000 USD20140506Open filing evidence
2013-10-01 – 2013-12-3189000000 USD20150206Open filing evidence
2013-07-01 – 2013-12-31178000000 USD20150206Open filing evidence
2013-07-01 – 2013-09-3089000000 USD20141107Open filing evidence
2012-07-01 – 2013-06-30344000000 USD20140811Open filing evidence
2013-01-01 – 2013-03-3188000000 USD20140506Open filing evidence
2012-07-01 – 2013-03-31254000000 USD20140506Open filing evidence
2012-10-01 – 2012-12-3186000000 USD20140206Open filing evidence
2012-07-01 – 2012-09-3080000000 USD20131108Open filing evidence
2011-07-01 – 2012-06-30317000000 USD20140811Open filing evidence

Other Medical Systems · Medical Systems

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cfn:OtherMedicalSystemsMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember
PeriodValueUnitFiledEvidence
2014-10-01 – 2014-12-316000000 USD20150206Open filing evidence
2014-07-01 – 2014-12-3111000000 USD20150206Open filing evidence
2014-07-01 – 2014-09-305000000 USD20141107Open filing evidence
2013-07-01 – 2014-06-3026000000 USD20140811Open filing evidence
2014-01-01 – 2014-03-316000000 USD20140506Open filing evidence
2013-07-01 – 2014-03-3120000000 USD20140506Open filing evidence
2013-10-01 – 2013-12-318000000 USD20150206Open filing evidence
2013-07-01 – 2013-12-3114000000 USD20150206Open filing evidence
2013-07-01 – 2013-09-306000000 USD20141107Open filing evidence
2012-07-01 – 2013-06-3027000000 USD20140811Open filing evidence
2013-01-01 – 2013-03-317000000 USD20140506Open filing evidence
2012-07-01 – 2013-03-3121000000 USD20140506Open filing evidence
2012-10-01 – 2012-12-317000000 USD20140206Open filing evidence
2012-07-01 – 2012-09-307000000 USD20131108Open filing evidence
2011-07-01 – 2012-06-3026000000 USD20140811Open filing evidence

Respiratory Technologies · Medical Systems

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cfn:RespiratoryTechnologiesMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember
PeriodValueUnitFiledEvidence
2014-10-01 – 2014-12-31106000000 USD20150206Open filing evidence
2014-07-01 – 2014-12-31191000000 USD20150206Open filing evidence
2014-07-01 – 2014-09-3085000000 USD20141107Open filing evidence
2013-07-01 – 2014-06-30377000000 USD20140811Open filing evidence
2014-01-01 – 2014-03-3194000000 USD20140506Open filing evidence
2013-07-01 – 2014-03-31278000000 USD20140506Open filing evidence
2013-10-01 – 2013-12-3196000000 USD20150206Open filing evidence
2013-07-01 – 2013-12-31184000000 USD20150206Open filing evidence
2013-07-01 – 2013-09-3088000000 USD20141107Open filing evidence
2012-07-01 – 2013-06-30393000000 USD20140811Open filing evidence
2013-01-01 – 2013-03-3197000000 USD20140506Open filing evidence
2012-07-01 – 2013-03-31300000000 USD20140506Open filing evidence
2012-10-01 – 2012-12-31106000000 USD20140206Open filing evidence
2012-07-01 – 2012-09-3097000000 USD20131108Open filing evidence
2011-07-01 – 2012-06-30420000000 USD20140811Open filing evidence

Specialty Disposables · Procedural Solutions

Product Or Service · Statement Business Segments

Source dimensions us-gaap:ProductOrServiceAxis=cfn:SpecialtyDisposablesMember;us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember
PeriodValueUnitFiledEvidence
2014-10-01 – 2014-12-31148000000 USD20150206Open filing evidence
2014-07-01 – 2014-12-31284000000 USD20150206Open filing evidence
2014-07-01 – 2014-09-30136000000 USD20141107Open filing evidence
2013-07-01 – 2014-06-30428000000 USD20140811Open filing evidence
2014-01-01 – 2014-03-31138000000 USD20140506Open filing evidence
2013-07-01 – 2014-03-31284000000 USD20140506Open filing evidence
2013-10-01 – 2013-12-3178000000 USD20150206Open filing evidence
2013-07-01 – 2013-12-31146000000 USD20150206Open filing evidence
2013-07-01 – 2013-09-3068000000 USD20141107Open filing evidence
2012-07-01 – 2013-06-30283000000 USD20140811Open filing evidence
2013-01-01 – 2013-03-3179000000 USD20140506Open filing evidence
2012-07-01 – 2013-03-31210000000 USD20140506Open filing evidence
2012-10-01 – 2012-12-3169000000 USD20140206Open filing evidence
2012-07-01 – 2012-09-3062000000 USD20131108Open filing evidence
2011-07-01 – 2012-06-30266000000 USD20140811Open filing evidence

International

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cfn:InternationalMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2014-06-30886000000 USD20140811Open filing evidence
2012-07-01 – 2013-06-30769000000 USD20140811Open filing evidence
2011-07-01 – 2012-06-30790000000 USD20140811Open filing evidence
2010-07-01 – 2011-06-30664000000 USD20130809Open filing evidence

Medical Systems

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember
PeriodValueUnitFiledEvidence
2014-10-01 – 2014-12-31645000000 USD20150206Open filing evidence
2014-07-01 – 2014-12-311173000000 USD20150206Open filing evidence
2014-07-01 – 2014-09-30528000000 USD20141107Open filing evidence
2013-07-01 – 2014-06-302394000000 USD20140811Open filing evidence
2014-01-01 – 2014-03-31571000000 USD20140506Open filing evidence
2013-07-01 – 2014-03-311682000000 USD20140506Open filing evidence
2013-10-01 – 2013-12-31587000000 USD20150206Open filing evidence
2013-07-01 – 2013-12-311111000000 USD20150206Open filing evidence
2013-07-01 – 2013-09-30524000000 USD20141107Open filing evidence
2012-07-01 – 2013-06-302329000000 USD20140811Open filing evidence
2013-01-01 – 2013-03-31584000000 USD20140506Open filing evidence
2012-07-01 – 2013-03-311737000000 USD20140506Open filing evidence
2012-10-01 – 2012-12-31602000000 USD20140206Open filing evidence
2012-07-01 – 2012-12-311153000000 USD20140206Open filing evidence
2012-07-01 – 2012-09-30551000000 USD20131210Open filing evidence
2011-07-01 – 2012-06-302439000000 RestatedUSD20140811Open filing evidence
2012-01-01 – 2012-03-31619000000 RestatedUSD20130510Open filing evidence
2011-07-01 – 2012-03-311769000000 RestatedUSD20130510Open filing evidence
2011-10-01 – 2011-12-31604000000 RestatedUSD20130208Open filing evidence
2011-07-01 – 2011-12-311150000000 RestatedUSD20130208Open filing evidence
2011-07-01 – 2011-09-30546000000 RestatedUSD20130208Open filing evidence
2010-07-01 – 2011-06-302214000000 RestatedUSD20131210Open filing evidence
2011-01-01 – 2011-03-31498000000 USD20120504Open filing evidence
2010-07-01 – 2011-03-311489000000 USD20120504Open filing evidence
2010-10-01 – 2010-12-31523000000 USD20120203Open filing evidence
2010-07-01 – 2010-12-31991000000 USD20120203Open filing evidence
2010-07-01 – 2010-09-30468000000 USD20111108Open filing evidence
2009-07-01 – 2010-06-302071000000 USD20130131Open filing evidence

Procedural Solutions

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember
PeriodValueUnitFiledEvidence
2014-10-01 – 2014-12-31424000000 USD20150206Open filing evidence
2014-07-01 – 2014-12-31818000000 USD20150206Open filing evidence
2014-07-01 – 2014-09-30394000000 USD20141107Open filing evidence
2013-07-01 – 2014-06-301448000000 USD20140811Open filing evidence
2014-01-01 – 2014-03-31397000000 USD20140506Open filing evidence
2013-07-01 – 2014-03-311038000000 USD20140506Open filing evidence
2013-10-01 – 2013-12-31335000000 USD20150206Open filing evidence
2013-07-01 – 2013-12-31641000000 USD20150206Open filing evidence
2013-07-01 – 2013-09-30306000000 USD20141107Open filing evidence
2012-07-01 – 2013-06-301221000000 USD20140811Open filing evidence
2013-01-01 – 2013-03-31317000000 USD20140506Open filing evidence
2012-07-01 – 2013-03-31910000000 USD20140506Open filing evidence
2012-10-01 – 2012-12-31307000000 USD20140206Open filing evidence
2012-07-01 – 2012-12-31593000000 USD20140206Open filing evidence
2012-07-01 – 2012-09-30286000000 USD20131210Open filing evidence
2011-07-01 – 2012-06-301159000000 RestatedUSD20140811Open filing evidence
2012-01-01 – 2012-03-31300000000 RestatedUSD20130510Open filing evidence
2011-07-01 – 2012-03-31868000000 RestatedUSD20130510Open filing evidence
2011-10-01 – 2011-12-31286000000 RestatedUSD20130208Open filing evidence
2011-07-01 – 2011-12-31568000000 RestatedUSD20130208Open filing evidence
2011-07-01 – 2011-09-30282000000 RestatedUSD20130208Open filing evidence
2010-07-01 – 2011-06-301226000000 RestatedUSD20131210Open filing evidence
2011-01-01 – 2011-03-31344000000 USD20120504Open filing evidence
2010-07-01 – 2011-03-311003000000 USD20120504Open filing evidence
2010-10-01 – 2010-12-31363000000 USD20120203Open filing evidence
2010-07-01 – 2010-12-31706000000 USD20120203Open filing evidence
2010-07-01 – 2010-09-30343000000 USD20111108Open filing evidence
2009-07-01 – 2010-06-301306000000 USD20130131Open filing evidence

United States

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cfn:UnitedStatesMember
PeriodValueUnitFiledEvidence
2012-07-01 – 2013-06-302781000000 USD20130809Open filing evidence
2011-07-01 – 2012-06-302808000000 USD20130809Open filing evidence
2010-07-01 – 2011-06-302776000000 USD20130809Open filing evidence

US

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=country:US
PeriodValueUnitFiledEvidence
2013-07-01 – 2014-06-302956000000 USD20140811Open filing evidence
2012-07-01 – 2013-06-302781000000 USD20140811Open filing evidence
2011-07-01 – 2012-06-302808000000 USD20140811Open filing evidence

Operating Segments

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2014-10-01 – 2014-12-311069000000 USD20150206Open filing evidence
2014-07-01 – 2014-12-311991000000 USD20150206Open filing evidence
2014-07-01 – 2014-09-30922000000 USD20141107Open filing evidence
2013-07-01 – 2014-06-303842000000 USD20140811Open filing evidence
2014-01-01 – 2014-03-31968000000 USD20140506Open filing evidence
2013-07-01 – 2014-03-312720000000 USD20140506Open filing evidence
2013-10-01 – 2013-12-31922000000 USD20150206Open filing evidence
2013-07-01 – 2013-12-311752000000 USD20150206Open filing evidence
2013-07-01 – 2013-09-30830000000 USD20141107Open filing evidence
2012-07-01 – 2013-06-303550000000 USD20140811Open filing evidence
2013-01-01 – 2013-03-31901000000 USD20140506Open filing evidence
2012-07-01 – 2013-03-312647000000 USD20140506Open filing evidence
2012-10-01 – 2012-12-31909000000 USD20140206Open filing evidence
2012-07-01 – 2012-12-311746000000 USD20140206Open filing evidence
2012-07-01 – 2012-09-30837000000 USD20131210Open filing evidence
2011-07-01 – 2012-06-303598000000 USD20140811Open filing evidence